Cargando…

Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) has developed as a pandemic, and it created an outrageous effect on the current healthcare and economic system throughout the globe. To date, there is no appropriate therapeutics or vaccines against the disease. The entire human race is eagerly waiting for the dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Chiranjib, Sharma, Ashish Ranjan, Bhattacharya, Manojit, Sharma, Garima, Saha, Rudra P., Lee, Sang-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937508/ https://www.ncbi.nlm.nih.gov/pubmed/33728098 http://dx.doi.org/10.4110/in.2021.21.e5

Ejemplares similares

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
por: Saha, Rudra P., et al.
Publicado: (2020)

Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics
por: Ghosh, Pratik, et al.
Publicado: (2021)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Response to: Status of Remdesivir: Not Yet Beyond Question!
por: Saha, Abinit, et al.
Publicado: (2021)

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
por: Saha, Abinit, et al.
Publicado: (2020)

Insight into Evolution and Conservation Patterns of B1-Subfamily Members of GPCR
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

MicroRNAs: Possible Regulatory Molecular Switch Controlling the BBB Microenvironment
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Evaluation and Designing of Epitopic-Peptide Vaccine Against Bunyamwera orthobunyavirus Using M-Polyprotein Target Sequences
por: Ghosh, Pratik, et al.
Publicado: (2021)

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2021)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Monkeypox virus vaccine evolution and global preparedness for vaccination
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

The current second wave and COVID-19 vaccination status in India
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia
por: Chakraborty, Chiranjib, et al.
Publicado: (2016)

Determination of k-mer density in a DNA sequence and subsequent cluster formation algorithm based on the application of electronic filter
por: Sarkar, Bimal Kumar, et al.
Publicado: (2021)

All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Integrative Bioinformatics Approaches Indicate a Particular Pattern of Some SARS-CoV-2 and Non-SARS-CoV-2 Proteins
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential
por: Sharma, Ashish Ranjan, et al.
Publicado: (2021)

D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4ci3qk4mes4attihe29ccdjbn